Comments Regarding Proposed Rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use Share page: Docket Number: FDA–2021–N–0862 Download Document Issues: OTC Medicines Rx-to-OTC Switch Related Posts Press Releases and Statements Tennessee Expands Access to OTC Cold & Allergy Medications Containing PSE May 7, 2024 Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Apr 25, 2024 Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024